{"nct_id":"NCT05340621","title":"NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2022-05-11","start_date_type":"ACTUAL","primary_completion_date":"2025-01-29","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["OKUR"]}